ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
13 announcements
Ambar Protein Industries Ltd has announced the closure of its share transfer books from September 24, 2026, to September 30, 2026, for its Annual General Meeting.
Ambar Protein Industries Ltd submitted its Annual Report for FY 2025-26, including the notice for the 33rd Annual General Meeting.
Ambar Protein Industries Ltd reported revenue from operations of ₹113.4 Cr (-3.3% YoY) and net profit of ₹3.8 Cr (+442.9% YoY) for Q1 FY27.
Ambar Protein Industries scheduled a board meeting for August 14, 2026, to discuss unaudited financial results and other operational matters.
Ambar Protein Industries clarified no undisclosed price-sensitive info exists. Share price movement is attributed to market conditions beyond company control.
Promoter Pradeep K. Khetani bought 13,200 shares (0.23%) of Ambar Protein Industries in an open‑market transaction on 23 June 2026. His holding rose to 12.66%.
Promoter Pradeep Kumar Chunilal Khetani acquired 22,378 shares (0.39%) via open market on June 9, 2026. His stake rose to 12.35%, signaling continued promoter confidence.
Ambar Protein Industries Ltd reported revenue from operations of ₹146.8 Cr (+14.9% YoY) and net profit of ₹2.5 Cr (+0.0% YoY) for Q4 FY26.
Ambar Protein Industries approved audited FY26 financial results, reporting annual revenue of ₹500.66 Crore. The Board also re-appointed Rajendra Natverlal Shah & Co. as internal auditors.
Ambar Protein Industries filed its Annual Secretarial Compliance Report for FY 2025-26. The auditor confirmed the company maintained proper governance standards with no observed non-compliances.
Ambar Protein Industries scheduled a board meeting for May 30, 2026. Directors will approve audited annual results and evaluate related party transactions with Ankur Oil Industries.
Ambar Protein Industries Ltd confirmed it does not fall under the 'Large Corporate' category for the financial year ended March 31, 2026. Consequently, the company reported nil incremental borrowing and no mandatory debt security issuance requirements under SEBI's large corporate framework for the 2025-26 period.
Ambar Protein Industries Ltd submitted an initial disclosure confirming it does not fall under the 'Large Corporate' category as of March 31, 2026. The company reported outstanding borrowings of ₹12.22 Crore, which is below the regulatory threshold specified in the SEBI Circular regarding fund raising by debt securities.